Brief: Acumen Pharmaceuticals, Inc. Q3 Income From Operations USD -26.513 Million
Nov 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q3 net income USD -26.451 million. Q3 basic EPS USD -0.44 Q3 operating expenses USD 26.513 million
Nov 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q3 net income USD -26.451 million. Q3 basic EPS USD -0.44 Q3 operating expenses USD 26.513 million